Michel Ducreux, ESMO 2019 - Treating advanced pancreatic cancer

(3:11)

Dr Pauline Hepato x Pr Michel Ducreux

(3:8)

Michel Ducreux, ESMO 2018 – Exploring new treatment options for hepatocellular carcinoma

(3:2)

Ask the author session with Prof. Michel Ducreux

(3:51)

Michel Ducreux, MD PhD, Institut Gustave Roussy, Paris, France

(1:21)

Pancreatic cancer: moving forward

(1:48)

Dr Ducreux on Findings From the TRANSMET Trial in Colorectal Liver Metastases

(1:43)

Pancreatic Cancer: peri-operative precision

(1:31)

Early diagnosis in advanced pancreatic cancer: how will we achieve this?

(1:40)

Synergy of anti-androgenic agents and immune checkpoint inhibitors in HCC

(2:4)

Cancer Contribution - L'interview de Michel Ducreux

(4:4)

New agents/strategies on the horizon in bile duct cancer

(15:26)

ESMO 2018 Congress TV Gender Medicine in Oncology with Michel Ducreux

(4:6)

Hepatocellular Carcinoma Debate - Logoregional treatment first

(12:3)

Dr. Michel Ducreux

(2:54)

Live Contribution - Témoignage n°7 - Michel Ducreux

(1:53)

Colorectal Cancer: New Drugs on the Horizon

(11:44)

Optimizing CRC and uHCC outcomes with TKIs

(1:58)

Portrait de Michel Ducreux, président du comité de jumelage

(1:13)